Chimeric Antigen Receptor Therapy for B-cell Malignancies
David L. Porter, Michael D. Kalos, Zhaohui Zheng, Bruce L. Levine, Carl H. June · Journal of Cancer · 2011
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2011
Abstract
We presented data showing that the CART-19 cells expressing the 4-1BB signaling domain can have unprecedented and massive in-vivo expansion, traffic to tumor sites, persist long term in vivo, and induce rapid and potent anti-tumor activity in chemotherapy refractory CLL patients.
Open the resolved locator · 10.7150/jca.2.331
Metadata licence: OpenAlex metadata (CC0)